Category: Expert Perspectives in Atopic Dermatitis

Lisa Swanson, MD: Insights on Maximum-use of Ruxolitinib Cream in Pediatric Patients with Atopic Dermatitis

Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients

Michael Cameron, MD, FAAD: Improving Itch and Quality of Life in Patients with Atopic Dermatitis

Dr. Michael Cameron discusses 52-week results showing rapid and lasting improvements in itch and quality of life with upadacitinib plus topical steroids. Topics Covered: Combination

James Song, MD: Personalizing Treatment for Atopic Dermatitis

Dr. James Song highlights the need for personalized approaches in atopic dermatitis care to predict treatment response and reduce trial-and-error prescribing. Topics Covered: Personalization in

James Song, MD, FAAD: Checking in on Long-term Safety Data on JAK Inhibitors for Atopic Dermatitis

Dr. James Song reviews the latest long-term safety data on topical and oral JAK inhibitors for managing atopic dermatitis**.** Topics Covered: Long-term safety of JAK

Melodie Young, MSN, RN, ANP-C: Treating Pediatric Patients with Atopic Dermatitis

Melodie Young, MSN, RN, ANP-C, discusses treating young children with atopic dermatitis and counseling caregivers on potential side effects. Topics Covered: Pediatric atopic dermatitis treatment

James Del Rosso, DO: Evaluating Effective Topical Therapies for Atopic Dermatitis
Dr. Del Rosso discusses the current topical treatments available for patients with atopic dermatitis that have shown consistent efficacy with limited adverse events.
Melodie Young, MSN, RN, ANP-C: Practical Aspects of Treating Patients with Atopic Dermatitis
Melodie Young discusses the logistics of gaining access to newer medications through speciality pharmacies for patients with atopic dermatitis.
Andrea Nguyen, PA-C, MS: Treatment Education for Patients with Atopic Dermatitis
Andrea Nguyen, PA-C, MS, discusses how the internet and social media has contributed to more in-depth discussion with her patients regarding treatment for atopic dermatitis.
Raj Chovatiya, MD, PhD: Atopic Dermatitis Patient Counseling for Moisturization
Dr. Chovatiya discusses the effectiveness of providing a moisturizer in combination with a topical or systemic therapy to achieve clear skin regardless of disease severity.
TJ Chao, PA-C: Considering Adverse Events in Patients with Atopic Dermatitis
TJ Chao breaks down the black box warnings for ruxolitinib cream 1.5% and discusses the importance in communicating the specifics of these warnings to patients.
Raj Chovatiya, MD: Key Ingredients in Moisturizers for Atopic Dermatitis
Dr. Chovatiya reviews some of the essentials to look for in moisturizers such as a treatment that is semipermeable and has natural moisturizing factors.
Raj Chovatiya, MD, PhD: Optimizing Atopic Dermatitis Treatment through Proper Moisturization
Dr. Chovatiya discusses the benefits of a moisturization routine as a complement to all currently available therapies for patients with atopic dermatitis.
TJ Chao, PA-C: Utilizing Topical Treatments for Patients with Atopic Dermatitis
Mr. Chao discusses the reliability of ruxolitinib cream 1.5% in treating patients with atopic dermatitis. He emphasized how well it is tolerated by patients, as
Matthew Zirwas, MD: Revolution of Topical Treatments in Atopic Dermatitis
Dr. Matthew Zirwas reviews atopic dermatitis treatments that have been essential in providing immediate improvement in itch leading to a sense of control in his
Jonathan I. Silverberg, MD, PhD, MPH, FAAD: Patient Counseling in Atopic Dermatitis
Dr. Silverberg discusses how to safely counsel patients when deciding between topical versus oral JAK inhibitors for the treatment of atopic dermatitis.